UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fecal microbiota transplantation in metabolic syndrome: History, present and future

Gut microbes, 2017-05, Vol.8 (3), p.253-267

2017

Volltextzugriff (PDF)

Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury

Gut microbes, 2022-12, Vol.14 (1), p.2027853-2027853

2022

Volltextzugriff (PDF)

Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis

Gut microbes, 2020-05, Vol.11 (3), p.569-580

2020

Volltextzugriff (PDF)

The potential role of Akkermansia muciniphila in liver health

Future microbiology, 2024-08, Vol.19 (12), p.1081

2024

Volltextzugriff (PDF)

Spotlight on avian pathology: Campylobacter hepaticus, the cause of Spotty Liver Disease in layers

Avian pathology, 2019-07, Vol.48 (4), p.285-287

2019

Volltextzugriff (PDF)

Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease

Gut microbes, 2024-12, Vol.16 (1), p.2372881

2024

Volltextzugriff (PDF)

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

Expert review of gastroenterology & hepatology, 2019-03, Vol.13 (3), p.193-204

2019

Volltextzugriff (PDF)

Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis

Medical mycology (Oxford), 2021-12, Vol.60 (1)

2021

Volltextzugriff (PDF)

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study

Bioengineered, 2021-01, Vol.12 (1), p.8233-8246

2021

Volltextzugriff (PDF)

Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine

Gut microbes, 2024, Vol.16 (1), p.2351620

2024

Volltextzugriff (PDF)

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

Gut microbes, 2023-12, Vol.15 (1), p.2223339-2223339

2023

Volltextzugriff (PDF)

Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice

Gut microbes, 2020-05, Vol.11 (3), p.265-275

2020

Volltextzugriff (PDF)

High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo

Gut microbes, 2021-01, Vol.13 (1), p.1979883-1979883

2021

Volltextzugriff (PDF)

Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

Expert review of gastroenterology & hepatology, 2015-01, Vol.9 (8), p.1069-1076

2015

Volltextzugriff (PDF)

MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis

Gut microbes, 2024-01, Vol.16 (1), p.2367342

2024

Volltextzugriff (PDF)

Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling

Gut microbes, 2024-01, Vol.16 (1), p.2390164

2024

Volltextzugriff (PDF)

Invasive aspergillosis in patients with liver disease

Medical mycology (Oxford), 2011-05, Vol.49 (4), p.406-413

2011

Volltextzugriff (PDF)

Adrenal and hepatic aspergillosis in an immunocompetent patient

Infectious diseases (London, England), 2015-06, Vol.47 (6), p.428-432

2015

Volltextzugriff (PDF)

Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis

Expert opinion on drug delivery, 2014-11, Vol.11 (11), p.1697-1712

2014

Volltextzugriff (PDF)

Effects of polysaccharide from Physalis alkekengi var. francheti on liver injury and intestinal microflora in type-2 diabetic mice

Pharmaceutical biology, 2017, Vol.55 (1), p.2020-2025

2017

Volltextzugriff (PDF)

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease

Drug design, development and therapy, 2019-07, Vol.13, p.2249-2270

2019

Volltextzugriff (PDF)

Gut non-bacterial microbiota contributing to alcohol-associated liver disease

Gut microbes, 2021-01, Vol.13 (1), p.1984122-1984122

2021

Volltextzugriff (PDF)

The gut microbiota and the liver: implications for clinical practice

Expert review of gastroenterology & hepatology, 2013-11, Vol.7 (8), p.723-732

2013

Volltextzugriff (PDF)

Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease

Scandinavian journal of gastroenterology, 2010-01, Vol.45 (2), p.160-167

2010

Volltextzugriff (PDF)

Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?

Expert review of gastroenterology & hepatology, 2018-10, Vol.12 (10), p.961-967

2018

Volltextzugriff (PDF)

1 – 25 von 1.092

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

KollektionTaylor & Francis Journals Auto-Holdings Collection

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(978)
Mit Volltextzugriff
(822)

Publikationsform

Artikel
(1.092)

Sprache

Englisch
(1.092)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(1.030)
Science & Technology
(1.030)
Humans
(657)
Male
(489)
Biological And Medical Sciences
(479)
Medical Sciences
(445)
Animals
(405)
Female
(373)
Biotechnology & Applied Microbiology
(333)
Gastroenterology. Liver. Pancreas. Abdomen
(323)
Infectious Diseases
(289)
Gastroenterology & Hepatology
(281)
Other Diseases. Semiology
(274)
Middle Aged
(249)
Adult
(242)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(200)
Aged
(181)
Microbiology
(167)
Liver
(156)
Mice
(138)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis Journals
(1.092)
MEDLINE
(926)
Taylor & Francis Journals
(863)
Taylor & Francis Online
(820)
Journals@Ovid Complete
(688)
Ingenta.com
(600)
IngentaConnect Journals
(589)
EZB Electronic Journals Library
(431)
Oxford Journals Online Current
(110)
Wiley Online Journals
(48)
Oxford Journals 2020 Medicine
(33)
Publisher or Other Site
(21)
Wiley Online Library
(16)
Psychology & Behavioral Sciences Collection
(3)
JSTOR
(2)
Applied Social Sciences Index & Abstracts (ASSIA)
(1)
ERIC
(1)
Cambridge Journals Online (DEFF)
(1)
SAGE Journals
(1)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Fecal microbiota transplantation in metabolic syndrome: History, present and future

Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury

Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis

The potential role of Akkermansia muciniphila in liver health

Spotlight on avian pathology: Campylobacter hepaticus, the cause of Spotty Liver Disease in layers

Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study

Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice

High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo

Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis

Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling

Invasive aspergillosis in patients with liver disease

Adrenal and hepatic aspergillosis in an immunocompetent patient

Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis

Effects of polysaccharide from Physalis alkekengi var. francheti on liver injury and intestinal microflora in type-2 diabetic mice

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease

Gut non-bacterial microbiota contributing to alcohol-associated liver disease

The gut microbiota and the liver: implications for clinical practice

Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease

Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?

Aktive Filter

Suchergebnisse filtern